BiomarkerResultGateChecker

Biomarker Result Gate

Liquid Biopsy жидкостная биопсия cfDNA ctDNA CTC exosomes NGS qPCR
Open selection

Utility description: Biomarker Result Gate

Biomarker Result Gate Checker — Biomarker Result Filtering Gate

ℹ️  Utility performs automatic multi-level filtering of identified genetic variants before clinical report generation according to AMP/ASCO/CAP guidelines and CAP Molecular Pathology Checklist:
     • Technical Gate: Exclusion of variants below validated VAF threshold (typically 1-5%).
     • Clinical Gate: Separation of variants into reportable (Tier I/II) and non-reportable (Tier III/IV/VUS).
     • Therapeutic Gate: Prioritization of variants with approved drugs or NCCN/ESMO recommendations.
     • Germline Gate: Isolation of hereditary mutations for separate report section.

⚠️  IMPORTANT: 
     • Utility is a decision support tool, not an expert replacement.
     • All filtered variants must be available to physician upon request for transparency.

Usage:
  BiomarkerResultGateChecker.exe                            → demo mode (console output)
  BiomarkerResultGateChecker.exe input.csv output.json      → evaluate your data

Input format:
SampleID,TumorType,Gene,Variant,VariantType,VAF_Percent,ClinicalTier,OncoKB_Level,HasApprovedTherapy,IsGermlinePathogenic,FilterReason

Example:
  NGS-001,NSCLC,EGFR,L858R,SNV,18.5,Tier I,Level 1,true,false,

📍 Scope of Application (Usage Where):
     • Clinical NGS Laboratories: Automatic draft report preparation.
     • Tumor Boards: Rapid identification of key findings.
     • Quality Control: Verification of consistency between bioinformatics output and clinical interpretation.
     • Regulatory Compliance: Documentation of variant inclusion/exclusion logic.

— WHY IS THIS NEEDED?
NGS panels identify hundreds of variants, most of which lack clinical significance.
Physicians should not waste time analyzing noise and VUS.
Automated gate guarantees that only actionable findings are presented in the report, reducing cognitive load and interpretation error risk.

⚠️  CRITICAL:
• VAF Threshold: Threshold must be validated for each variant type and panel.
• Tier Classification: Classification must be based on current knowledge bases.
• Germline Findings: Hereditary mutations require special reporting format and genetic counseling.
• Transparency: Physician must have access to full variant list including filtered ones.

Key features:
• Multi-level filtering system (Technical → Clinical → Therapeutic)
• Support for AMP/ASCO/CAP classification and OncoKB levels
• Automatic isolation of germline findings
• Summary report generation per sample
• Compliance with CAP/CLIA requirements

Critical parameters:
• VAF: ≥ Validated Threshold
• Clinical Tier: I or II for main report
• Approved Therapy: Presence of drug association
• Germline Status: Correct labeling of hereditary variants

💡 Usage tips:
1. Threshold Tuning: Adapt VAF thresholds to your panel sensitivity.
2. Knowledge Bases: Regularly update Tier and OncoKB level directories.
3. Manual Review: Always provide override capability for complex cases.
4. Documentation: Save filtering logic as part of audit trail.
5. Training: Physicians must understand variant inclusion criteria.

⚠️ Note: This utility is a Clinical Decision Support tool. Final decision on variant inclusion in report is made by molecular pathologist or clinical geneticist.

input.csv

SampleID,TumorType,Gene,Variant,VariantType,VAF_Percent,ClinicalTier,OncoKB_Level,HasApprovedTherapy,IsGermlinePathogenic,FilterReason
NGS-2026-001,NSCLC,EGFR,L858R,SNV,18.5,Tier I,Level 1,true,false,
NGS-2026-001,NSCLC,TP53,R248Q,SNV,12.0,Tier IV,None,false,false,VUS - No clinical significance
NGS-2026-001,NSCLC,BRCA2,c.5946delT,Indel,48.0,Tier I,Level 1,true,true,
NGS-2026-001,NSCLC,KRAS,G12D,SNV,0.8,Tier I,Level 1,true,false,Below validated VAF threshold
NGS-2026-002,CRC,BRAF,V600E,SNV,25.0,Tier I,Level 1,true,false,
NGS-2026-002,CRC,APC,R1450*,SNV,35.0,Tier IV,None,false,false,Benign/Likely Benign

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of BiomarkerResultGateChecker for Biomarker Result Gate Checker.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • • Germline Gate: Isolation of hereditary mutations for separate report section.
  • • All filtered variants must be available to physician upon request for transparency.
  • NGS panels identify hundreds of variants, most of which lack clinical significance.
  • ⚠️ CRITICAL:
  • • VAF Threshold: Threshold must be validated for each variant type and panel.
  • • Tier Classification: Classification must be based on current knowledge bases.
  • • Transparency: Physician must have access to full variant list including filtered ones.
  • • Automatic isolation of germline findings
  • Critical parameters:
  • • VAF: ≥ Validated Threshold
  • 5. Training: Physicians must understand variant inclusion criteria.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file for Biomarker Result Gate Checker with headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.HighIdentical input data, rule version and configuration produce reproducible results.
URS-003The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.HighSchema, conversion and range errors are explicitly reported.
URS-004The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.HighEach check has PASS/WARNING/FAIL and a clear message.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall preserve traceability between batch/sample, input file, applied rules and final status.HighOutput contains identifiers, checked parameters and audit metadata.
URS-007The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.MediumURS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.MediumDocumentation states change control and limit-verification expectations.

input.csv contract

#FieldTypeSamplePurpose
1SampleIDstring / controlled vocabularyNGS-2026-001Sample or laboratory specimen identifier.
2TumorTypestring / controlled vocabularyNSCLCControlled input parameter for deterministic QC rules.
3Genestring / controlled vocabularyEGFRControlled input parameter for deterministic QC rules.
4Variantstring / controlled vocabularyL858RControlled input parameter for deterministic QC rules.
5VariantTypestring / controlled vocabularySNVControlled input parameter for deterministic QC rules.
6VAF_Percentdecimal18.5Controlled input parameter for deterministic QC rules.
7ClinicalTierstring / controlled vocabularyTier IControlled input parameter for deterministic QC rules.
8OncoKB_Levelstring / controlled vocabularyLevel 1Controlled input parameter for deterministic QC rules.
9HasApprovedTherapystring / controlled vocabularytrueControlled input parameter for deterministic QC rules.
10IsGermlinePathogenicstring / controlled vocabularyfalseControlled input parameter for deterministic QC rules.
11FilterReasonstring / controlled vocabularyControlled input parameter for deterministic QC rules.
SampleID,TumorType,Gene,Variant,VariantType,VAF_Percent,ClinicalTier,OncoKB_Level,HasApprovedTherapy,IsGermlinePathogenic,FilterReason
NGS-2026-001,NSCLC,EGFR,L858R,SNV,18.5,Tier I,Level 1,true,false,
NGS-2026-001,NSCLC,TP53,R248Q,SNV,12.0,Tier IV,None,false,false,VUS - No clinical significance
NGS-2026-001,NSCLC,BRCA2,c.5946delT,Indel,48.0,Tier I,Level 1,true,true,

Input validation rules

IDFieldRuleCriticality
VR-001SampleIDThe field shall match an approved dictionary or accepted string representation.High
VR-002TumorTypeThe field shall match an approved dictionary or accepted string representation.High
VR-003GeneThe field shall match an approved dictionary or accepted string representation.High
VR-004VariantThe field shall match an approved dictionary or accepted string representation.Medium
VR-005VariantTypeThe field shall match an approved dictionary or accepted string representation.Medium
VR-006VAF_PercentThe field shall match an approved dictionary or accepted string representation.Medium
VR-007ClinicalTierThe field shall match an approved dictionary or accepted string representation.Medium
VR-008OncoKB_LevelThe field shall match an approved dictionary or accepted string representation.Medium
VR-009HasApprovedTherapyThe field shall match an approved dictionary or accepted string representation.Medium
VR-010IsGermlinePathogenicThe field shall match an approved dictionary or accepted string representation.Medium
VR-011FilterReasonThe field shall match an approved dictionary or accepted string representation.Medium

FS — Functional Specification

IDFunctionImplementation
FS-001CLI executionSupport execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002CSV importRead input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003Schema validationCheck mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004Type conversionConvert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005Domain rule engineApply rules for Biomarker Result Gate Checker, including critical limits from the description and approved specification.
FS-006Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008Audit supportKeep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009Integration contractSupport the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010Error handlingReturn explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "biomarkerresultgatechecker",
  "utilityFolder": "BiomarkerResultGateChecker",
  "package": "LiquidBiopsy",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "SampleID",
      "value": "NGS-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "TumorType",
      "value": "NSCLC",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "Gene",
      "value": "EGFR",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "Variant",
      "value": "L858R",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "VariantType",
      "value": "SNV",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "VAF_Percent",
      "value": "18.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "ClinicalTier",
      "value": "Tier I",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "OncoKB_Level",
      "value": "Level 1",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    },
    {
      "parameter": "HasApprovedTherapy",
      "value": "true",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-009"
    },
    {
      "parameter": "IsGermlinePathogenic",
      "value": "false",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-010"
    },
    {
      "parameter": "FilterReason",
      "value": "",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-011"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "BiomarkerResultGateChecker.documentation.html"
  }
}

Traceability matrix

URSFSTestEvidence
URS-001FS-001, FS-002OQ-001Verify execution and import of valid input.csv.
URS-002FS-005, FS-006OQ-004Repeat the same dataset and compare output.json.
URS-003FS-003, FS-004, FS-010OQ-002, OQ-003Verify missing columns and invalid types.
URS-004FS-005, FS-006OQ-004, PQ-001Verify critical deviations on real/boundary data.
URS-005FS-007, FS-009OQ-005Verify JSON schema and downstream-system suitability.
URS-006FS-008OQ-006Verify identifiers and audit metadata.
URS-007FS-008, FS-010IQ-001, OQ-007Verify documentation completeness and control evidence.
URS-008FS-005, FS-008PQ-002Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

IDScenarioExpected result
IQ-001Verify executable, input.csv, documentation and checksum availability.Delivery set is complete; version is recorded.
OQ-001Valid sample row from input.csv.PASS or acceptable WARNING according to rules.
OQ-002Remove a mandatory CSV column.Schema error or FAIL with missing-column reference.
OQ-003Place a non-numeric value into a numeric field.Type-conversion error with row/field reference.
OQ-004Set a critical parameter outside the limit.FAIL and critical finding.
OQ-005Verify output.json structure.All mandatory sections are present and JSON is valid.
OQ-006Verify batch/sample traceability.Input and result identifiers match.
PQ-001Verify 3–5 real user batches/samples.Result is confirmed by QC/QA review.
PQ-002Verify deviation workflow and manual QA decision.Utility supports review but does not replace approved decision.

QA/QC and change control

  • Do not rename columns without updating validator, documentation and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
  • The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Liquid Biopsy QC Suite

QC and pre-analytical control package for liquid biopsy workflows: cfDNA/ctDNA, CTC, EV/exosomes, methylation, NGS/qPCR/ddPCR, sample quality, contamination, sensitivity and reporting checks.

Open